Johns Hopkins ABX Guide
Entecavir
INDICATIONS
FDA
FDA
- Treatment of chronic hepatitis B (HBV) infection in adults and children at least 2 years of age with evidence of active disease (active viral replication, elevated ALT or AST or histologic evidence of active disease).
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: October 2, 2017
Citation
Smith, Janessa, and Paul A Pham. "Entecavir." Johns Hopkins ABX Guide, The Johns Hopkins University, 2017. Pediatrics Central, peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540200/all/Entecavir.
Smith J, Pham PA. Entecavir. Johns Hopkins ABX Guide. The Johns Hopkins University; 2017. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540200/all/Entecavir. Accessed November 21, 2024.
Smith, J., & Pham, P. A. (2017). Entecavir. In Johns Hopkins ABX Guide. The Johns Hopkins University. https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540200/all/Entecavir
Smith J, Pham PA. Entecavir [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2017. [cited 2024 November 21]. Available from: https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540200/all/Entecavir.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Entecavir
ID - 540200
A1 - Smith,Janessa,Pharm.D. BCPS
AU - Pham,Paul,Pharm.D.
Y1 - 2017/10/02/
BT - Johns Hopkins ABX Guide
UR - https://peds.unboundmedicine.com/pedscentral/view/Johns_Hopkins_ABX_Guide/540200/all/Entecavir
PB - The Johns Hopkins University
DB - Pediatrics Central
DP - Unbound Medicine
ER -
